The global RNAi technology market, valued at US$2.75 billion in 2024, is projected to reach US$6.63 billion by 2033 at a 10.4% CAGR. Explore drivers like FDA approvals of Onpattro, Givlaari, and Leqvio, advances in GalNAc conjugates and lipid nanoparticles, and expansions in rare genetic disorders and oncology amid biotech partnerships. https://finance.yahoo.com/news/rnai-technology-market-size-reach-150000762.html